Cargando…

Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection

INTRODUCTION: Nivolumab demonstrated significant recurrence-free survival (RFS) gains versus ipilimumab in the CheckMate-238 trial, whereas the CA184-029 trial showed superior RFS gains for ipilimumab versus placebo. No head-to-head trial data were available to compare the efficacy of nivolumab to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batteson, Rachael, Hart, Rose, Hemstock, Matthew, Gooden, Kyna, Kotapati, Srividya, Roze, Stephane, Lee, Dawn, Amadi, Adenike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248152/ https://www.ncbi.nlm.nih.gov/pubmed/31587138 http://dx.doi.org/10.1007/s41669-019-00181-y

Ejemplares similares

Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis
por: Toor, Kabirraaj, et al.
Publicado: (2021)

Cost–Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France
por: Bregman, Bruno, et al.
Publicado: (2020)

Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma
por: Samlowski, Wolfram, et al.
Publicado: (2022)

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
por: Potluri, Ravi, et al.
Publicado: (2019)

Societal preferences for adjuvant melanoma health states: UK and Australia
por: Middleton, Mark R., et al.
Publicado: (2017)

Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma
por: Federico Paly, Victoria, et al.
Publicado: (2022)

Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma
por: Zhang, Ying, et al.
Publicado: (2015)

Adjuvant radiation therapy in metastatic lymph nodes from melanoma
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2011)

Cost-Utility of Nivolumab Plus Ipilimumab in First-Line Treatment of Advanced Melanoma in the United States: An Analysis Using Long-Term Overall Survival Data from Checkmate 067
por: Baker, Timothy, et al.
Publicado: (2022)

Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
por: Eroglu, Zeynep, et al.
Publicado: (2022)

Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England
por: Lee, D., et al.
Publicado: (2018)

Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England
por: Lee, D., et al.
Publicado: (2018)

Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
por: Falk Delgado, Alberto, et al.
Publicado: (2019)

Primary amelanotic malignant melanoma of the male urethra with inguinal lymph node metastasis successfully controlled by nivolumab: A case report
por: Tokita, Takashi, et al.
Publicado: (2018)

Cost-Effectiveness of Pembrolizumab for the Adjuvant Treatment of Melanoma Patients with Lymph Node Involvement Who Have Undergone Complete Resection in Argentina
por: Wurcel, Victoria, et al.
Publicado: (2021)

Subcostal lymph nodes: An unusual sentinel lymph node basin in cutaneous melanoma
por: Marsh, Katherine M., et al.
Publicado: (2022)

Survival and the Sentinel Lymph Node in Melanoma
por: Faries, Mark
Publicado: (2009)

Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting
por: Gutjahr, Alice, et al.
Publicado: (2016)

Nivolumab exposure–response analysis for adjuvant treatment of melanoma supporting a change in posology
por: Sanghavi, Kinjal, et al.
Publicado: (2021)

Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection
por: Lopez-Vinueza, Cesar, et al.
Publicado: (2023)

Cutaneous Melanoma and Sentinel Lymph Node Biopsy
por: van Akkooi, A. C. J., et al.
Publicado: (2008)

Missing sentinel lymph node in cutaneous melanoma
por: Dellavedova, Luca, et al.
Publicado: (2015)

Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients
por: Vuoristo, Mikko, et al.
Publicado: (2021)

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
por: Mandalá, Mario, et al.
Publicado: (2021)

Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
por: Weber, Jeffrey S., et al.
Publicado: (2023)

A Case of Advanced Gastroesophageal Junction Cancer with Bulky Lymph Node Metastases Treated with Nivolumab
por: Nakamura, Naohiko, et al.
Publicado: (2020)

Laparoscopically assisted ilio-inguinal lymph node dissection versus inguinal lymph node dissection in melanoma
por: Boldo, Enrique, et al.
Publicado: (2020)

Analysis of Time Between Skin Lesion and Lymph Node Biopsies and Lymph Node Metastasis in Patients With Melanoma
por: Le, Elliot L. H., et al.
Publicado: (2023)

Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes
por: Lamrayah, Myriam, et al.
Publicado: (2023)

PASSIVE TRANSFER OF ADJUVANT ARTHRITIS BY LYMPH NODE OR SPLEEN CELLS
por: Pearson, Carl M., et al.
Publicado: (1964)

Ocular Melanoma Metastasizing to Intra-Abdominal Lymph Nodes
por: Aranovich, David, et al.
Publicado: (2013)

Regression and Sentinel Lymph Node Status in Melanoma Progression
por: Letca, Alina Florentina, et al.
Publicado: (2018)

Recent Evolution in the Management of Lymph Node Metastases in Melanoma
por: Breit, Shelby, et al.
Publicado: (2021)

Methods of Sentinel Lymph Node Identification in Auricular Melanoma
por: Noorbakhsh, Seth, et al.
Publicado: (2021)

Sentinel node biopsy and radical lymph node dissection for advanced melanoma in the elderly
por: Desiato, V, et al.
Publicado: (2011)

The Number of Nodes Examined in the Sentinel Lymph Node Biopsy Dictates Melanoma Survival
por: Bateman, Daniela Duarte, et al.
Publicado: (2023)

Locoregional Lymph Node Recurrence of Trunk Melanoma in Non-sentinel Lymph Node Basins: An Observational Retrospective Study
por: MORO, Ruggero, et al.
Publicado: (2020)

Melanoma Inhibitory Activity and regional lymph node status in malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015)

Lymph Node Number Predicts the Efficacy of Adjuvant Chemoradiotherapy in Node-Positive Endometrial Cancer Patients
por: Lee, Jie, et al.
Publicado: (2020)

Adjuvant Treatment Approaches after Radical Prostatectomy with Lymph Node Involvement
por: Tavukçu, Hasan Hüseyin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_37bpo93d7c6cnivp7dn4joi304